A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury

Table 4 The changing of antioxidative enzymes levels (ΔAOE) after 4 weeks of treatment (AOE at week 4 - AOE at baseline)

	ΔAOE after 4 weeks of treatment
	Silymarin	Placebo	p-value
SOD^a (%)	−0.20 (−4.0, 6.4)	−4.41 (−6.0, 1.8)	0.027
Glutathione^a (ng/ul)	−0.09 (−0.3, 0.0)	−011 (−0.2, 0.0)	0.83
MDA^a (nmol/L)	−0.14 (−13.5, 17.1)	−9.74 (−23.8, 6.0)	0.22

ISSN: 2662-7671